Skip to main content

Beneficial effect of cerebrolysin on moderate and severe head injury patients: result of a cohort study

  • Conference paper
Intracranial Pressure and Brain Monitoring XII

Part of the book series: Acta Neurochirurgica Supplementum ((NEUROCHIRURGICA,volume 95))

Summary

Cerebrolysin is used as a neurotrophic agent for the treatment of ischemic stroke and Alzheimer’s Disease. Exploratory studies in patients with post-acute traumatic brain injury have shown that this treatment might help improve recovery. Aim of this study was to investigate whether addition of Cerebrolysin to the initial treatment regimen of moderate and severe head injury patients would improve their outcome.

At 6 months, 67% of the patients (Cerebrolysin group) attained good outcome (GOS 3–5). The study group was compared with the historical cohort of patients from the hospital trauma data bank, with age, sex and admitting GCS matching. More patients tended to a good outcome in the Cerebrolysin group (P = 0.065). No significant side-effect requiring cessation of Cerebrolysin was noted.

It can be concluded that the use of Cerebrolysin as part of the initial management of moderate and severe head injury is safe and well tolerated. The results suggest that Cerebrolysin is beneficial in regard to the outcome in these patients, especially in elderly patients.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 219.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Anton A, Sampedro C, Perez P et al (2003) Positive effects of Cerebrolysin on electroencephalogram slowing, cognition and clinical outcome in patients with postacute traumatic brain injury: an exploratory study. International Clinical Psychopharmacology 18: 271–278

    Article  Google Scholar 

  2. Bae CY, Cho CY, Cho K et al (2000) A double-blind, placebo-controlled, multicenter study of cerebrolysin for Alzheimer’s Disease. Journal of American Geriatric Society 48: 1566–1571

    CAS  Google Scholar 

  3. Jennett B, Bond M (1975) Assessment of outcome after severe brain damage, a practical scale. Lancet 1: 480–484

    Article  PubMed  CAS  Google Scholar 

  4. Jennett B, Teasdale G, Braakman R (1979) Prognosis of patients with severe brain injury. Neurosurgery 4: 283–289

    PubMed  CAS  Google Scholar 

  5. Katz DI, Alexander MP (1994) Traumatic brain injury. Predicting course of recovery and outcome for patients admitted to rehabilitation. Arch Neurol 51(7): 661–670

    PubMed  CAS  Google Scholar 

  6. Prigatano GP (1988) Rehabilitation intervention after traumatic brain injury. BNI Quarterly 4: 30–37

    Google Scholar 

  7. Rice-Oxley M, Turner-Stokes L (1999) Effectiveness of brain injury rehabilitation. Clin Rehab 13(S1): 7–24

    Article  Google Scholar 

  8. Ruether E, Ritter R, Apecechea M, Freytag S, Gmeinbauer R, Windisch M (2000) Sustained improvements in patients with dementia of Alzheimer’s type (DAT) 6 months after termination of cerebrolysin therapy. J Neural Transm 107(7): 815–829

    Article  Google Scholar 

  9. Valouskova V, Francis-Turner L (1998) Can cerebrolysin influence chronic deterioration of spatial learning and memory? J Neural Transm [Suppl] 53: 343–349

    CAS  Google Scholar 

  10. Wilson JTL, Pettigrew LEL, Teasdale GM (2000) Emotional and cognitive consequences of head injury in relation to the Glasgow outcome scale. J Neurol Neurosurg Psychiatry 69: 204–209

    Article  PubMed  CAS  Google Scholar 

  11. Xiao S, Yan H, Yao P: The Cerebrolysin Study Group (2000) Efficacy of FPF 1070 (Cerebrolysin) in patients with Alzheimer’s Disease. Clin Drug Invest 19(1): 43–53

    Article  CAS  Google Scholar 

  12. Zhu XL, Poon WS, Chan CH, Chan SH (2001) Does intensive rehabilitation improve the functional outcome of patients with traumatic brain injury? Interim result of a randomized controlled trial. Brit J Neurosurg 15(6): 464–473

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to W. S. Poon .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2005 Springer-Verlag

About this paper

Cite this paper

Wong, G.K.C., Zhu, X.L., Poon, W.S. (2005). Beneficial effect of cerebrolysin on moderate and severe head injury patients: result of a cohort study. In: Poon, W.S., et al. Intracranial Pressure and Brain Monitoring XII. Acta Neurochirurgica Supplementum, vol 95. Springer, Vienna. https://doi.org/10.1007/3-211-32318-X_13

Download citation

  • DOI: https://doi.org/10.1007/3-211-32318-X_13

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-24336-7

  • Online ISBN: 978-3-211-32318-2

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics